By Sheri Kasprzak
New York, July 31 - pSivida Ltd. concluded a private placement of subordinated convertible debentures for $6.5 million.
Absolute Europe Catalyst Fund, Absolute Octane Fund and Australian IT Investments Ltd. bought the 8% debentures, which are due in three years.
The debentures are convertible into American Depositary Shares at $2.00 each.
The debentures may be redeemed at any time at 108% of face value plus interest. The company may force conversion of the debentures if its stock trades above $4.00 for more than 25 consecutive trading days.
The investors received warrants for ADS equal to 90% of the principal of new outstanding debentures divided by the conversion price. The warrants are exercisable at $2.00 each for five years.
Mercury Investments Ltd. was the placement agent.
Based in Perth, Western Australia, pSivida makes nanotechnology products used by pharmaceutical and other medical providers.
Issuer: | pSivida Ltd.
|
Issue: | Subordinated convertible debentures
|
Amount: | $6.5 million
|
Maturity: | Three years
|
Coupon: | 8%
|
Price: | Par
|
Yield: | 8%
|
Conversion price: | Into ADS at $2.00 each
|
Call: | Redeemable at 108% of par plus interest; may force conversion if stock trades above $4.00 for 25 consecutive trading days
|
Warrants: | Equal to 90% of the outstanding principal divided by the conversion price
|
Warrant expiration: | Five years
|
Warrant strike price: | $2.00
|
Investors: | Absolute Europe Catalyst Fund, Absolute Octane Fund and Australian IT Investments Ltd.
|
Placement agent: | Mercury Investments Ltd.
|
Settlement date: | July 31
|
Stock symbol: | Nasdaq: PSDV
|
Stock price: | $2.84 at close July 28
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.